Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 57

    1.

    Map of differential transcript expression in the normal human large intestine.

    LaPointe LC, Dunne R, Brown GS, Worthley DL, Molloy PL, Wattchow D, Young GP.

    Physiol Genomics. 2008 Mar 14;33(1):50-64. Epub 2007 Dec 4.PMID: 18056783 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Bisulphite differential denaturation PCR for analysis of DNA methylation.

    Rand KN, Mitchell SM, Clark SJ, Molloy PL.

    Epigenetics. 2006 Apr-Jun;1(2):94-100. Epub 2006 Mar 7.PMID: 17998815 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    DNA methylation: bisulphite modification and analysis.

    Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M.

    Nat Protoc. 2006;1(5):2353-64.PMID: 17406479 [PubMed - indexed for MEDLINE]Related articles

    4.

    DNA hypomethylation and human diseases.

    Wilson AS, Power BE, Molloy PL.

    Biochim Biophys Acta. 2007 Jan;1775(1):138-62. Epub 2006 Sep 1. Review.PMID: 17045745 [PubMed - indexed for MEDLINE]Related articles

    5.

    Headloop suppression PCR and its application to selective amplification of methylated DNA sequences.

    Rand KN, Ho T, Qu W, Mitchell SM, White R, Clark SJ, Molloy PL.

    Nucleic Acids Res. 2005 Aug 9;33(14):e127.PMID: 16091627 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.

    Wang XY, Martiniello-Wilks R, Shaw JM, Ho T, Coulston N, Cooke-Yarborough C, Molloy PL, Cameron F, Moghaddam M, Lockett TJ, Webster LK, Smith IK, Both GW, Russell PJ.

    Gene Ther. 2004 Nov;11(21):1559-67.PMID: 15343359 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies.

    Russell PJ, Hewish D, Carter T, Sterling-Levis K, Ow K, Hattarki M, Doughty L, Guthrie R, Shapira D, Molloy PL, Werkmeister JA, Kortt AA.

    Cancer Immunol Immunother. 2004 May;53(5):411-21. Epub 2004 Jan 13.PMID: 14722668 [PubMed - indexed for MEDLINE]Related articles

    8.

    Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells.

    Messina M, Yu DM, Both GW, Molloy PL, Robinson BG.

    J Clin Endocrinol Metab. 2003 Mar;88(3):1310-8.PMID: 12629124 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Transcription-targeted gene therapy for androgen-independent prostate cancer.

    Martiniello-Wilks R, Tsatralis T, Russell P, Brookes DE, Zandvliet D, Lockett LJ, Both GW, Molloy PL, Russell PJ.

    Cancer Gene Ther. 2002 May;9(5):443-52.PMID: 11961667 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma.

    Schmitt JF, Millar DS, Pedersen JS, Clark SL, Venter DJ, Frydenberg M, Molloy PL, Risbridger GP.

    Mol Endocrinol. 2002 Feb;16(2):213-20.PMID: 11818495 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.

    Uchida A, O'Keefe DS, Bacich DJ, Molloy PL, Heston WD.

    Urology. 2001 Aug;58(2 Suppl 1):132-9.PMID: 11502468 [PubMed - indexed for MEDLINE]Related articles

    12.

    A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

    Watt F, Martorana A, Brookes DE, Ho T, Kingsley E, O'Keefe DS, Russell PJ, Heston WD, Molloy PL.

    Genomics. 2001 May 1;73(3):243-54.PMID: 11350116 [PubMed - indexed for MEDLINE]Related articles

    13.

    Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy.

    Gong MC, Chang SS, Watt F, O'Keefe DS, Bacich DJ, Uchida A, Bander NH, Reuter VE, Gaudin PB, Molloy PL, Sadelian M, Heston WD.

    Mol Urol. 2000 Fall;4(3):217-22;discussion 223. Review.PMID: 11062377 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.

    O'Keefe DS, Uchida A, Bacich DJ, Watt FB, Martorana A, Molloy PL, Heston WD.

    Prostate. 2000 Oct 1;45(2):149-57.PMID: 11027414 [PubMed - indexed for MEDLINE]Related articles

    15.

    High level, tissue-specific expression of a modified calcitonin/calcitonin gene-related peptide promoter in a human medullary thyroid carcinoma cell line.

    Messina M, Yu DM, Learoyd DL, Both GW, Molloy PL, Robinson BG.

    Mol Cell Endocrinol. 2000 Jun;164(1-2):219-24.PMID: 11026573 [PubMed - indexed for MEDLINE]Related articles

    16.

    A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5'-end of the GSTP1 CpG island.

    Millar DS, Paul CL, Molloy PL, Clark SJ.

    J Biol Chem. 2000 Aug 11;275(32):24893-9.PMID: 10779522 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Electrophoretic mobility shift assays.

    Molloy PL.

    Methods Mol Biol. 2000;130:235-46. Review. No abstract available. PMID: 10589435 [PubMed - indexed for MEDLINE]Related articles

    18.

    Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.

    Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ.

    Oncogene. 1999 Feb 11;18(6):1313-24.PMID: 10022813 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene.

    O'Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, Zandvliet D, Russell PJ, Molloy PL, Nowak NJ, Shows TB, Mullins C, Vonder Haar RA, Fair WR, Heston WD.

    Biochim Biophys Acta. 1998 Nov 26;1443(1-2):113-27.PMID: 9838072 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors.

    Lockett LJ, Molloy PL, Russell PJ, Both GW.

    Clin Cancer Res. 1997 Nov;3(11):2075-80.PMID: 9815599 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...